story|Posted:3/31/22|Last Updated:3/31/22

House passes bill to cap insulin copays at $35 a month for Medicare, private plans

0 Comments
The House passed a bill Thursday that caps the out-of-pocket cost of insulin at $35 a month for beneficiaries in Medicare Part D and for certain group and individual plans. The Affordable Insulin Now Act, which passed the House via a 232-193 vote, comes as work in the Senate continues on a bipartisan alternative that could bring additional changes. Under the bill, a Part D beneficiary’s cost-sharing would be no more than $35 for a 30-day supply of insulin. The cap also would apply to either $35 or 25% of the plan’s negotiated price for a 30-day supply. Private plans would be required to offer first-dollar coverage of insulin without any deductible, according to an analysis from the Congressional Budget Office. The cap on cost-sharing for private insurance plans would take effect in 2023.
Document Files
No document files.